Journals / Clinical and Experimental Ocular Trauma and Infection / 2026 / Volume: 2 Issue: 2

Glaucoma and Possible Risks During SARS-CoV-2 Pandemic

Mehmet Murat Uzel(BALIKESİR ÜNİVERSİTESİ, TIP FAKÜLTESİ)
Pages
—
Publication Date
2020-08-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Nevertheless, it is recommended to postpone routine eye examinations except in emergencies.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has led to a rapid change worldwide.
📊
Key Findings & Data:In ophthalmological examination, it was stated that the risk of virus transmission is high.
💡
Conclusion & Impact:Nevertheless, it is recommended to postpone routine eye examinations except in emergencies.
🔬Design:Letter to Editor
📍Scope:Comprehensive Sample
⚙️Variables:glaucoma · covid-19

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has led to a rapid change worldwide. In ophthalmological examination, it was stated that the risk of virus transmission is high. For this reason, special protective equipment had to be put into use. In addition, proper sterilization of the instruments used in the examination and reorganization of the waiting room have gained importance. Nevertheless, it is recommended to postpone routine eye examinations except in emergencies. Glaucoma is a disease managed in the light of the findings obtained during routine examinations. Prolonged pandemic process may lead to irreversible optic nerve damage in patient groups that move away from routine examination.

🔖

Cite This Article

Uzel, M. M. (2020). Glaucoma and Possible Risks During SARS-CoV-2 Pandemic. Clinical and Experimental Ocular Trauma and Infection, Volume: 2 Issue: 2. https://ajindex.com/articles/1582561

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (6)

  1. World Health Organization. Coronavirus disease (COVID-19) pandemic.https://www.who.int/emergencies/diseases/novel-coronavirus-2019
  2. Xia J, Tong J, Liu M, Shen Y, Guo D. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection. J Med Virol. 2020; Feb 26 [Epub ahead of print].
  3. Seah IYJ, Anderson DE, Kang AEZ, Wang L, Rao P, Young BE et al. Assessing viral Shedding and infectivity of tears in coronavirus disease 2019 (COVID-19) patients. Ophthalmology. 2020 Mar 24. Pii: S0161-6420(20)30311-0.
  4. Wu P, Duan F, Luo C, Liu Q, Qu, X, Liang L et al. Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei province, China. JAMA Ophthalmol. 2020 Mar 31. Doi:10.1001/jamaophthalmol.2020.1291. [Epub ahead of print].
  5. Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014 Nov;121(11):2081-90. doi: 10.1016/j.ophtha.2014.05.013.
  6. Li C, Tang Y, Chen Z, Wang A, Huang X, Chen Y, et al. Aerosol formation during non-contact “air-puff” tonometry and its significance for prevention of COVID-19. Chin J Exp Ophthalmol. 2020;38(0):E010.